< Major Announcements After Market Close >
◆ InBody = Q1 operating profit of 5.6 billion KRW… down 14% YoY
◆ CJ Freshway = Q1 operating loss of 12.6 billion KRW… turned to deficit
◆ Sollid = Decision to issue 10 billion KRW private CB
◆ SFC = Korea Exchange "SFC delisting resolution"
◆ Gamevil = Q1 operating profit of 6.2 billion KRW… turned to profit YoY
◆ Samchundang Pharmaceutical = Approval of Phase 3 clinical trial plan for Eylea biosimilar
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![From Bar Hostess to Organ Seller to High Society... The Grotesque Con of a "Human Counterfeit" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
